BioGend Therapeutics Co., Ltd. (6733.TWO)
TWD 27.65
(-3.49%)
TWD 27.65
(-3.49%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -317.41 Million TWD | -114.65% |
| 2022 | -147.87 Million TWD | -12.11% |
| 2021 | -131.9 Million TWD | -9.88% |
| 2020 | -120.03 Million TWD | -33.71% |
| 2019 | -89.77 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -144.44 Million TWD | 72.2% |
| 2024 Q1 | -519.63 Million TWD | -63.71% |
| 2023 Q4 | -317.41 Million TWD | 7.72% |
| 2023 FY | -317.41 Million TWD | -114.65% |
| 2023 Q3 | -343.97 Million TWD | 1.8% |
| 2023 Q2 | -350.28 Million TWD | 24.94% |
| 2023 Q1 | -466.65 Million TWD | -191.37% |
| 2022 Q4 | -160.15 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | -20.157% |
| Level Biotechnology Inc. | -453.9 Million TWD | 30.069% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 163.503% |
| GlycoNex Incorporation | -148.56 Million TWD | -113.653% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 888.303% |
| OBI Pharma, Inc. | -398.22 Million TWD | 20.292% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 330.021% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 1138.06% |
| Visgeneer Inc. | 31.28 Million TWD | 1114.634% |
| Neith Corporation | -150.31 Million TWD | -111.174% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 23.076% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 151.07% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -450.519% |
| Enimmune corporation | -314.15 Million TWD | -1.037% |
| TaiRx, Inc. | -147.86 Million TWD | -114.662% |
| CHO Pharma, Inc. | -203.79 Million TWD | -55.756% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -274.477% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 362.609% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 3.97% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -1502.069% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 725.393% |
| RBC Bioscience Corporation | 422.18 Million TWD | 175.185% |
| NaviFUS Corp. | -123.12 Million TWD | -157.793% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 66.39% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -212.77% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -92.17% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -163.264% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 1097.887% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -393.49% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -136.434% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -31.222% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 90.137% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -311.996% |
| AP Biosciences Inc | -196.52 Million TWD | -61.513% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 53.362% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 200.808% |
| EirGenix Inc. | -4.58 Billion TWD | 93.082% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 61.743% |
| Mycenax Biotech Inc. | 207 Million TWD | 253.335% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | -20.883% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -51.629% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | -61.621% |
| VBI | -25.31 Million TWD | -1153.824% |
| BiOptic Inc. | 12.59 Million TWD | 2620.791% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 528.648% |
| Sinew Pharma Inc. | -160.34 Million TWD | -97.959% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 5.915% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 146.087% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -2675.361% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 123.386% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 23.491% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -120.639% |
| TCI GENE Inc. | -689.25 Million TWD | 53.947% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -166.877% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 75.755% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 1649.666% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -211.591% |
| PharmaEngine, Inc. | -860.8 Million TWD | 63.126% |
| Savior Lifetec Corporation | -812.54 Million TWD | 60.935% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | -5.817% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 13.136% |
| Acepodia, Inc. | -6.02 Billion TWD | 94.727% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 90.669% |